The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

When diagnosed with HIV, the timing of treatment initiation can significantly impact long-term health outcomes and quality of life. Medical experts increasingly advocate for immediate treatment ...

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...

You may have heard about Symtuza, a medicine approved by the FDA in 2018 to treat people with HIV who have not been treated yet. It may also be used to replace another medicine for treating HIV in ...

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade, since the ...

A new analysis finds that generic lenacapavir, a twice-yearly HIV preventive treatment, could be mass produced for just $25 ...

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults ...

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV population and people with HIV who are heavily treated with those have ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...